fda bpc-157 status 2026 Peptide news worth paying attention to. The FDA's Pharmacy Compounding Advisory Committee just voted YES to recommend BPC-157, TB-500, KPV, and MOTS-c for the 503A compounding list. This isn't approval. That FDA July 2026 Peptide Meeting:

Physician-Supervised Care GFE from Medical Director (~5 min, 1 year)

the Wolverine Stack or GLOW), letting you pick an "anchor compound" to calculate a single fluid volume for the entire multi-mg vial with zero guesswork

Scientific Investigation Use Only BPC-157 is intended strictly for in-vitro research purposes and may be incorporated into tissue repair research peptide, connective tissue research peptide, and extracellular matrix research peptide models within laboratory-based experimental frameworks

Moreover, GHS peptides are currently a banned doping agent in professional sports, and little is known about their long-term safety

& Park, S

Let's establish one thing at the beginning